
USD
$0.00
(0.00%
)At Close (As of Oct 24, 2025)
$4.02B
Market Cap
-
P/E Ratio
-1.59
EPS
$41.47
52 Week High
$14.06
52 Week Low
HEALTHCARE
Sector
| Field | Value (USD) |
|---|---|
| Gross Profit | $46M |
| Total Revenue | $46M |
| Cost Of Revenue | $113K |
| Costof Goods And Services Sold | $113K |
| Operating Income | -$176M |
| Selling General And Administrative | $70M |
| Research And Development | $151M |
| Operating Expenses | $222M |
| Investment Income Net | - |
| Net Interest Income | $17M |
| Interest Income | $17M |
| Interest Expense | $0 |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $113K |
| Income Before Tax | -$242M |
| Income Tax Expense | -$1K |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | -$242M |
| Comprehensive Income Net Of Tax | - |
| Ebit | -$242M |
| Ebitda | -$241M |
| Net Income | -$242M |
| Field | Value (USD) |
|---|---|
| Total Assets | $865M |
| Total Current Assets | $863M |
| Cash And Cash Equivalents At Carrying Value | $772M |
| Cash And Short Term Investments | $772M |
| Inventory | - |
| Current Net Receivables | $21M |
| Total Non Current Assets | $1.2M |
| Property Plant Equipment | - |
| Accumulated Depreciation Amortization Ppe | - |
| Intangible Assets | $534K |
| Intangible Assets Excluding Goodwill | $534K |
| Goodwill | - |
| Investments | - |
| Long Term Investments | - |
| Short Term Investments | $62M |
| Other Current Assets | $7.9M |
| Other Non Current Assets | - |
| Total Liabilities | $107M |
| Total Current Liabilities | $107M |
| Current Accounts Payable | $4.7M |
| Deferred Revenue | - |
| Current Debt | - |
| Short Term Debt | $246K |
| Total Non Current Liabilities | $202K |
| Capital Lease Obligations | $448K |
| Long Term Debt | - |
| Current Long Term Debt | - |
| Long Term Debt Noncurrent | - |
| Short Long Term Debt Total | $448K |
| Other Current Liabilities | $96M |
| Other Non Current Liabilities | - |
| Total Shareholder Equity | $758M |
| Treasury Stock | - |
| Retained Earnings | -$559M |
| Common Stock | $13M |
| Common Stock Shares Outstanding | $94M |
| Field | Value (USD) |
|---|---|
| Operating Cashflow | -$159M |
| Payments For Operating Activities | - |
| Proceeds From Operating Activities | - |
| Change In Operating Liabilities | - |
| Change In Operating Assets | - |
| Depreciation Depletion And Amortization | $113K |
| Capital Expenditures | $672K |
| Change In Receivables | - |
| Change In Inventory | - |
| Profit Loss | - |
| Cashflow From Investment | -$63M |
| Cashflow From Financing | $660M |
| Proceeds From Repayments Of Short Term Debt | - |
| Payments For Repurchase Of Common Stock | - |
| Payments For Repurchase Of Equity | - |
| Payments For Repurchase Of Preferred Stock | - |
| Dividend Payout | - |
| Dividend Payout Common Stock | - |
| Dividend Payout Preferred Stock | - |
| Proceeds From Issuance Of Common Stock | - |
| Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
| Proceeds From Issuance Of Preferred Stock | - |
| Proceeds From Repurchase Of Equity | - |
| Proceeds From Sale Of Treasury Stock | - |
| Change In Cash And Cash Equivalents | - |
| Change In Exchange Rate | - |
| Net Income | -$242M |
| Field | Value (USD) |
|---|---|
| Gross Profit | $46M |
| Total Revenue | $46M |
| Cost Of Revenue | $113K |
| Costof Goods And Services Sold | $113K |
| Operating Income | -$176M |
| Selling General And Administrative | $70M |
| Research And Development | $151M |
| Operating Expenses | $222M |
| Investment Income Net | - |
| Net Interest Income | $17M |
| Interest Income | $17M |
| Interest Expense | $0 |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $113K |
| Income Before Tax | -$242M |
| Income Tax Expense | -$1K |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | -$242M |
| Comprehensive Income Net Of Tax | - |
| Ebit | -$242M |
| Ebitda | -$241M |
| Net Income | -$242M |
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
None